CHIRALABS

Updated 999 days ago
Private Limited Company
  • Active - 04437177 (CH)
  • Age: 22 years
  • ID: 45139638/6
Critchleys-Beaver House, 23-28 Hythe Bridge Street, Oxford, Oxfordshire, OX1 2ET, UK
• 72190 - Other research and experimental development on natural sciences and engineering
Chiralabs provides expertise in the characterisation of molecular products, their processes, behaviour and properties, for research and development in the pharmaceutical, biotechnology and chemical industries. We are particularly able to support companies in pursuing complex spectroscopic and physicochemical investigations beyond their in-house resources. We provide a route for enhanced discovery and development through access to specialist knowledge and technology. Chiralabs is particularly adept at co-ordinating industry-academia collaborations and the translation of research based techniques to the industrial environment... Chiralabs provides contract expert chemical, biochemical and physical analysis services and undertakes investigative, problem-solving studies of substances and products in a wide range of fields, including for the consumer, pharmaceutical, biopharmaceutical, biotechnology, health, nutrition, food, plastics, chemical, engineering and waste industries. We..
Also known as: CHIRALABS LIMITED, Chiralabs Ltd
Registration numbers: 04437177 (CH), 4437177 (W)
Primary location: Oxford United Kingdom
Associated domains: chiralabs.co.uk, chiralabs.eu, chiralabs.info, chiralabs.net
  • 0
  • 0
Interest Score
2
HIT Score
0.33

UK Company Data

Company number
04437177
Account category
MICRO ENTITY
Account ref. day
30
Account ref. month
4
Accounts next due date
2025-01-31
Accounts last made up date
2023-04-30
Returns next due date
2017-06-10
Returns last made up date
2016-05-13
Num. mort. charges
0
Num. mort. outstanding
0
Num. mort. part. satisfied
0
Num. mort. satisfied
0
Num. gen. partners
0
Num. lim. partners
0
Domain
chiralabsxl.com

Actual
www.chiralabsxl.com

IP
217.160.0.142

Status
OK

Category
Company
0 comments Add a comment